Public Act 103-0659

HB4055 Enrolled LRB103 31972 BMS 60758 b

AN ACT concerning regulation.

Be it enacted by the People of the State of Illinois,

represented in the General Assembly:

Section 5. The Prior Authorization Reform Act is amended

by adding Section 77 as follows:

(215 ILCS 200/77 new)

Sec. 77. Prior authorization for drug therapies for

hereditary bleeding disorders. Notwithstanding any other

provision of law, a health insurance issuer or a contracted

utilization review organization may not require a prior

authorization for drug therapies approved by the U.S. Food and

Drug Administration for the treatment of hereditary bleeding

disorders any more frequently than 6 months or the length of

time the prescription for that dosage remains valid, whichever

period is shorter.